EOM Pharmaceutical Holdings Inc. (IMUC)

[skitstovel]

What a POS is DNDN. It costs a trillion dollars to make a single dose that barely, if at all, increases the prognosis over SOC.
The price/dose is where IMUC shines. No matter what happens in PII, their process has huge value that, I think, is too easily overlooked. ANY co. that attacks cancer this way will employ it. In a way, it's like owning a cancer stem cell ETF.
Also the news about antigen levels (about a month ago) gives me measure of confidence greater that the PI results, which I discount more than most it seems.